-
Characterization of metallothionein-I-transgenic mice.
Toxicol Appl Pharmacol. 1995 Aug;133(2):305-12
PMID: 7645027
-
Possible role of oxidative damage in metal-induced carcinogenesis.
Cancer Invest. 1995;13(4):411-30
PMID: 7627727
-
In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.
Chem Res Toxicol. 2002 Mar;15(3):319-25
PMID: 11896678
-
Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Clin Cancer Res. 2001 Dec;7(12):3869-73
PMID: 11751477
-
Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents.
Nucleic Acids Res. 1984 Feb 24;12(4):2137-45
PMID: 6701097
-
Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Biochemistry. 1996 Sep 10;35(36):11529-35
PMID: 8794732
-
Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Mol Med. 2001 Jul;7(7):442-53
PMID: 11683369
-
Characterization of mouse cell lines resistant to nickel(II) ions.
Cancer Res. 1988 Dec 1;48(23):6850-4
PMID: 3180093
-
Role of FHIT in human cancer.
J Clin Oncol. 1999 May;17(5):1618-24
PMID: 10334551
-
Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Cancer Res. 2000 Jun 1;60(11):2780-5
PMID: 10850413
-
Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol.
J Inorg Biochem. 1982 Aug;17(1):29-39
PMID: 7119773
-
Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice.
Mol Cell Biol. 1993 Sep;13(9):5266-75
PMID: 8355681
-
The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells.
Cancer Res. 1998 Aug 1;58(15):3401-8
PMID: 9699672
-
The importance of proteins in defense against oxidation.
Antioxid Redox Signal. 2001 Apr;3(2):293-311
PMID: 11396483
-
FHIT as tumor suppressor: mechanisms and therapeutic opportunities.
Cancer Biol Ther. 2002 May-Jun;1(3):232-6
PMID: 12432269
-
Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
Biochem J. 2000 Dec 1;352 Pt 2:443-8
PMID: 11085938
-
Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Cancer Res. 1999 Jul 15;59(14):3333-9
PMID: 10416589
-
Induction of apoptosis in cells by cadmium: quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate.
Toxicol Sci. 2001 Dec;64(2):208-15
PMID: 11719703
-
Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis.
Oncology. 2001;61(3):205-11
PMID: 11574776
-
The role of the FHIT/FRA3B locus in cancer.
Annu Rev Genet. 1998;32:7-31
PMID: 9928473
-
Metallothioneins: new functional and structural insights.
Curr Opin Chem Biol. 2000 Apr;4(2):177-83
PMID: 10742189
-
Enhancement of hydroxylation and deglycosylation of 2'-deoxyguanosine by carcinogenic nickel compounds.
Cancer Res. 1989 Nov 1;49(21):5964-8
PMID: 2790811
-
Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5484-9
PMID: 9576908
-
Effects of cadmium and zinc on solar-simulated light-irradiated cells: potential role of zinc-metallothionein in zinc-induced genoprotection.
Arch Biochem Biophys. 2002 Sep 15;405(2):170-7
PMID: 12220529
-
Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity.
J Toxicol Sci. 1998 Jul;23 Suppl 2:97-102
PMID: 9760441
-
The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8489-92
PMID: 10411902
-
The histidine triad superfamily of nucleotide-binding proteins.
J Cell Physiol. 1999 Nov;181(2):179-87
PMID: 10497298
-
Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
Cancer Res. 2002 Jun 15;62(12):3477-84
PMID: 12067991
-
MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family.
Structure. 1997 Jun 15;5(6):763-74
PMID: 9261067
-
Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis.
Free Radic Biol Med. 2002 May 15;32(10):958-67
PMID: 12008111
-
Carcinogenicity of nickel compounds in animals.
IARC Sci Publ. 1984;(53):127-42
PMID: 6532978
-
Replacement of Fhit in cancer cells suppresses tumorigenicity.
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13771-6
PMID: 9391102
-
Frequent altered expression of fragile histidine triad protein in human colorectal adenomas.
Biochem Biophys Res Commun. 2000 Nov 11;278(1):205-10
PMID: 11071873
-
The tumor suppressor protein Fhit. A novel interaction with tubulin.
J Biol Chem. 1999 Aug 20;274(34):24378-82
PMID: 10446217
-
Zinc resistance impairs sensitivity to oxidative stress in HeLa cells: protection through metallothioneins expression.
Free Radic Biol Med. 2001 Nov 15;31(10):1179-90
PMID: 11705696
-
FHIT gene therapy prevents tumor development in Fhit-deficient mice.
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3346-51
PMID: 11248081
-
Production of metallothionein and heat-shock proteins in response to metals.
Fundam Appl Toxicol. 1993 Jul;21(1):15-22
PMID: 8365580